MAT Monitoring Lab Services

MAT Monitoring Lab Services

Medication-assisted treatment depends on accurate, timely lab results. Results Diagnostics provides COLA-accredited, CLIA-certified toxicology testing specifically designed to support MAT programs — with 24-hour turnaround on all standard panels and direct billing to Medicare, Medicaid, and commercial insurance.

What We Test For in MAT Programs

Medication Compliance Monitoring

Confirm patients are taking prescribed medications as directed:

  • Buprenorphine (BUP) — Suboxone, Subutex adherence monitoring
  • Methadone (MTD) — Methadone maintenance compliance
  • Naltrexone — Vivitrol/Revia confirmation testing
  • Naloxone — Presence confirmation in combination products

Illicit Drug Screening

Comprehensive UDS panels to detect concurrent substance use:

  • Full opioid panel (morphine, oxycodone, fentanyl, heroin metabolites)
  • Stimulants (cocaine, methamphetamine, amphetamines, MDMA)
  • Benzodiazepines, barbiturates, THC, alcohol (ETG)
  • Synthetic opioids including fentanyl and analogs

Confirmatory Testing

Presumptive positives confirmed by LC-MS/MS — the gold standard for medicolegal defensibility in MAT programs.

Why MAT Programs Choose Results Diagnostics

✅ 24-Hour Standard Turnaround

Results back the next business day — so your clinical team can make timely treatment decisions without delays.

✅ COLA-Accredited, CLIA-Certified

Full COLA accreditation and CLIA certification means your results meet the highest standards for clinical and legal defensibility.

✅ Direct Insurance Billing

We bill Medicare, Medicaid, and commercial insurance directly. Your facility pays nothing and manages no claims.

✅ Dedicated Account Support

A single point of contact for your program — not a call center. Questions get answered same day.

✅ Chain of Custody Documentation

Every result is documented for medicolegal defensibility — critical for programs serving patients involved in drug court or probation.

Common MAT Program Use Cases

  • Opioid Use Disorder (OUD) programs — buprenorphine and methadone monitoring
  • Alcohol Use Disorder (AUD) programs — ETG/ETS monitoring up to 80 hours post-consumption
  • Drug court and probation-referred patients — chain of custody documentation
  • Dual-diagnosis programs — psychiatric medication adherence monitoring
  • Residential and outpatient MAT programs

Frequently Asked Questions

What is your turnaround time for MAT panels?

24 hours standard. Results are delivered electronically to your clinical team the next business day.

Does our facility pay for testing?

No. We bill the patient’s Medicare, Medicaid, or commercial insurance directly. Your facility receives no invoice.

Do you support both buprenorphine and methadone programs?

Yes. We test for buprenorphine, norbuprenorphine, methadone, EDDP (methadone metabolite), naltrexone, and naloxone.

Can you detect fentanyl and synthetic opioids?

Yes. Our panel includes fentanyl, norfentanyl, acetylfentanyl, carfentanil, and other fentanyl analogs.

What accreditations do you hold?

CLIA certified (CMS #29D2310339), COLA accredited, and CAP proficiency testing participant.

Ready to Partner With Us?

Call us at 702-830-5100 or contact us to set up a no-cost consultation. We’ll review your current testing program and show you exactly what a partnership with Results Diagnostics looks like.

Results Diagnostics LLC  |  5580 S. Fort Apache Rd, Unit 120, Las Vegas, NV 89148  |  NPI: 1063253094